Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma

Our study identifies OXSM as a key DRG hub gene in glioma, with elevated expression strongly correlating with poor patient prognosis. The observed relationship between OXSM expression and immune cell infiltration suggests its potential role in modulating the glioma microenvironment. These findings advance our understanding of glioma's molecular mechanisms and may inform the development of novel therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-09-26
DOI
https://doi.org/10.1007/s12672-025-03491-2
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma

Shengdong Nie, Jinchao Zhu, Qingyuan Lin, Yijuan Fan et al.
1 citations
Discover Oncology
Glioma Diagnosis and Treatment
1.63
article

Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma

Shengdong Nie, Jinchao Zhu, Qingyuan Lin, Yijuan Fan, Ke Yao, Wenhuan Guo, Weiyao Zhu
article en
1 citations

Abstract

Our study identifies OXSM as a key DRG hub gene in glioma, with elevated expression strongly correlating with poor patient prognosis. The observed relationship between OXSM expression and immune cell infiltration suggests its potential role in modulating the glioma microenvironment. These findings advance our understanding of glioma's molecular mechanisms and may inform the development of novel therapeutic strategies.

Discover OncologyVol. 16(1)
University of Shanghai for Science and Technology (CN), Renji Hospital (CN), Shanghai Ninth People's Hospital (CN)
Natural Science Foundation of Shanghai, National Natural Science Foundation of China, Shanghai Key Laboratory of Molecular Imaging
Openalex Percentile: Top 13%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Disulfidptosis OXSM serves as a potential prognostic biomarker and correlates with immune infiltrates in glioma — Shengdong Nie, Jinchao Zhu, et al. · Discover Oncology (2025) | TGRS Research Map | TGRS